Atherectomy Systems

Last updated on August 26, 2016
CompanyProduct
AvingerPantheris
Boston ScientificJetstream Atherectomy System
Boston ScientificPeripheral Rotablator Rotational Atherectomy System
Boston ScientificCoronary Rotablator Rotational Atherectomy System
Cardiovascular Systems Inc.Diamondback 360 Coronary Orbital Atherectomy System
Cardiovascular Systems Inc.Diamondback 360 Peripheral Orbital Atherectomy System
Cardiovascular Systems Inc.Stealth 360 Peripheral Orbital Atherectomy System
Philips VolcanoPhoenix Atherectomy System - 1.8 mm Tracking Catheter
Philips VolcanoPhoenix Atherectomy System - 2.2 mm Tracking Catheter
Philips VolcanoPhoenix Atherectomy System - 2.4 mm Deflecting Catheter

Related Content

First U.S. Patients Treated With Second-Generation Pantheris Atherectomy Device
News | Atherectomy Devices | July 18, 2018
First U.S. Patients Treated With Second-Generation Pantheris Atherectomy Device
Avinger Inc. announced in June that several physicians have successfully treated over 40 patients for peripheral artery...
read more
Avinger Receives FDA Clearance of Next-Generation Pantheris Device
Technology | Atherectomy Devices | May 24, 2018
Avinger Receives FDA Clearance of Next-Generation Pantheris Device
Avinger Inc. announced that the company received 510(k) clearance from the U.S. Food & Drug Administration (FDA)...
read more
Medtronic Receives FDA Clearance for Riptide Aspiration System
Technology | Atherectomy Devices | January 16, 2018
Medtronic Receives FDA Clearance for Riptide Aspiration System
Medtronic plc announced the company’s Neurovascular business unit received U.S. Food and Drug Administration (FDA)...
read more
Avinger Announces Treatment of First Patients With Next-Generation Pantheris
News | Atherectomy Devices | January 09, 2018
Avinger Announces Treatment of First Patients With Next-Generation Pantheris
January 9, 2018 – Avinger Inc. announced that Arne Schwindt, M.D., a vascular surgeon at St.
read more
Avinger Receives 510(k) Clearance for Pantheris Image-Guided Atherectomy Device Modifications
Technology | Atherectomy Devices | November 20, 2017
Avinger Receives 510(k) Clearance for Pantheris Image-Guided Atherectomy Device Modifications
November 20, 2017 — Avinger Inc. announced in October that the company received 510(k) clearance from the U.S.
read more
Avinger Receives CE Mark for In-Stent Restenosis Indication With Pantheris Image-Guided Atherectomy
Technology | Atherectomy Devices | September 29, 2017
Avinger Receives CE Mark for In-Stent Restenosis Indication With Pantheris Image-Guided Atherectomy
Avinger Inc. recently announced Conformité Européenne (CE) Marking approval for treating in-stent restenosis with the...
read more
Ra Medical Systems Receives FDA Clearance for New Peripheral Artery Disease Treatment
Technology | Atherectomy Devices | May 30, 2017
Ra Medical Systems Receives FDA Clearance for New Peripheral Artery Disease Treatment
The U.S. Food and Drug Administration (FDA) announced that it has granted market clearance to Ra Medical Systems for...
read more
CSI recall for saline pump on its atherectomy system
News | Atherectomy Devices | April 19, 2017
Cardiovascular Systems Initiates Voluntary Recall of Atherectomy Saline Infusion Pump
Cardiovascular Systems Inc. (CSI) announced April 18 it had initiated a voluntary recall of its 7-10014 Saline Infusion...
read more
Cardiovascular Systems Inc., CSI, ECLIPSE clinical trial, Diamondback 360 Coronary Orbital Atherectomy System, first subject enrolled
News | Atherectomy Devices | April 04, 2017
Cardiovascular Systems Enrolls First Subject in ECLIPSE Coronary Clinical Trial
Cardiovascular Systems Inc., in partnership with the Cardiovascular Research Foundation (CRF), announced the first...
read more
CSI, LIBERTY 360 Study, ISET 2017, six-month data, lower extremity PAD
News | Atherectomy Devices | February 08, 2017
LIBERTY 360 Study Demonstrates Sustained Benefit of Endovascular Intervention in Lower Extremity PAD
February 8, 2017 — Cardiovascular Systems (CSI) presented six-month data from its LIBERTY 360° post-market study in a
read more
© Copyright Scranton Gillette Communications. All Rights Reserved.
Overlay Init